Abstract
Changes in quality-of-life perceptions and their relations to clinical status for 41 adult outpatients living with HIV/AIDS were assessed over a 4-year period. Clinical variables and quality-of-life (Medical Outcomes Study Short-Form-36) ratings were measured in three waves (T1, 1997; T2, 1999; T3, 2001). Mean T1–T3 CD4 increase was 196 cells/μL (p < .0001), corresponding to a mean viral load reduction of 1.4 log10 copies/mL (p < .0001) and an increase in proportions with “undetectable” viral load status from 32% to 61% (p < .01). The T1–T2 increase in overall mean number of symptoms (including both disease–related symptom complex and treatment side effects) was mitigated by T2–T3 symptom reduction. Quality-of-life dimensions were generally stable or slightly improved over time for the overall sample, a finding that contrasts with pre-highly active antiretroviral therapy longitudinal research. Mental aspects of quality of life remained consistently lower than reference norms. Results of multiple regression suggested that quality of life was less sensitive to immunologic/virologic changes compared to responsiveness to symptom changes, consistent with cross-sectional inverse relations between symptom burden and quality of life. CD4 repletion offset negative effects of symptoms for some aspects of quality of life. The long-term course of quality of life was somewhat predicted by viral load suppression due to the conjoint influence of symptoms and CD4 count.
Similar content being viewed by others
References
Badia, X., Podzamczer, D., Garcia, M., Lopez-David, C., and Consiglio, E. (1999). A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. AIDS, 13, 1727-1735.
Bassetti, S., Battegay, M., Furrer, H., Rickenback, M., Flepp, M., Kaiser, L., Telenti, A., Vernazza, P. L., Bernasconi, E., and Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?; Journal of AIDS, 21, 114-119.
Burgoyne, R. W., and Saunders, D. S. (2001). Quality of life among urban Canadian HIV/AIDS clinic outpatients. International Journal of STD and AIDS, 12, 505-512.
Carrieri, P., Spire, B., Duran, S., Katlama, C., Peyramond, D., Francois, C., Chene, G., Lang, J. M., Moatti, J. P., and Leport, C. (2003). Health-related quality of life after 1 year of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 32, 38-47.
Catz, S. L., Kalichman, S. C., Benotsch, E. G., Miller, J., and Suarez, T. (2001). Anticipated psychological impact of receiving medical feedback about HIV treatment outcomes. AIDS Care, 13, 631-635.
Chan, K., and Revicki, D. A. (1998). Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus. Evaluation and the Health Professions, 21, 265-281.
Cohen, C., Revicki, D. A., Nabulsi, A., Sarocco, P. W., and Jiang, P. (1998). A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS, 12, 1495-1502.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.) Hillsdale, NJ: Erlbaum.
Cunningham, W. E., Shapiro, M. F., Hays, R. D., Dixon, W. J., Visscher, B. R., George, L., Ettl, M. K., and Beck, C. K. (1998). Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. American Journal of Medicine, 104, 129-136.
De Boer, J. B., Sprangers, M. A., Aaronson, N. K., Lange, J. M., and Van Dam, F. S. (1994). The feasibility, reliability and validity of the EORTC QLQ-C30 in assessing the quality of life of patients with a symptomatic HIV infection or AIDS. Psychology and Health, 9, 65-77.
Gange, S. J., Jacobson, L. P., Kass, N., Bing, E., Chmiel, J. S., Zucconi, S. L., and Graham, N. M. (1996, July). Quality of life among HIV seropositive men on monotherapy and combination antiretroviral therapy [abstract We.B.3341]. Paper presented at the International Conference on AIDS, Vancouver, Canada.
Hogg, R. S., Heath, K., Yip, B., Craib, K., O'Shaughnessy, M., Schecter, M., and Montaner, J. (1998). Improved survival among HIV-infected individuals following initiation of antiviral therapy. Journal of the American Medical Association, 279, 450-454.
Justice, A. C., Rabeneck, L., Hays, R. D., Wu, A. W., and Bozzette, S. A. (1999). Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Journal of AIDS, 21, 126-133.
Justice, A. C., Chang, C. H., Rabeneck, L., and Zackin, R. (2001). Clinical importance of provider-reported HIV symptoms compared with patient-report. Medical Care, 39, 397-408.
Kaplan, R. M., Anderson, J. P., Patterson, T. L., McCutchan, J. A., Weinrich, J. D., Heaton, R. K., Atkinson, J. H., Thal, L., Chandler, J., and Grant, I. (1995). Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. Psychosomatic Medicine, 57, 138-147.
Kazis, L. E., Anderson, J. J., and Meenen, R. F. (1989). Effect sizes for interpreting change in health status. Medical Care, 27, S178-S189.
Lenderking, W. R., Gelber, R. D., Cotton, D. J., Cole, B. F., Goldhirsch, A., Volberding, P. A., and Testa, M. (1994). Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 330, 738-743.
Low-Beer, S., Chan, K., Wood, E., Yip, B., Montaner, J. S., O'Shaughnessy, M. V., and Hogg, R. S. (2001). Health related quality of life among persons with HIV after the use of protease inhibitors. Quality of Life Research, 9, 941-949.
Lubeck, D. P., and Fries, J. F. (1994). Changes in health status after one year for persons at-risk for and with HIV infection. Psychology and Health, 9, 79-92.
Lubeck, D. P., and Fries, J. F. (1997). Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS time-oriented health outcome study (ATHOS). Quality of Life Research, 6, 494-506.
Murri, R., Ammassari, A., Fantoni, M., and Scoppettuolo, G. (1997). Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV health survey. Journal of AIDS and Human Retrovirology, 16, 350-356.
Nieuwkerk, P. T., Gisolf, E. H., Colebunders, R., Wu, A. W., Danner, S. A., and Sprangers, M. A. (2000). Quality of life in asymptomatic and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS, 14, 181-187.
Nieuwkerk, P. T., Gisolf, E. H., Reijers, M. H., Lange, J. M., Danner, S. A., and Sprangers, M. A. (2001). Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS, 15, 1985-1991.
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
Rabkin, J. G., Ferrando, S. J., Lin, S., Sewell, M., and McElhiney, M. (2000). Psychological effects of HAART: A 2-year study. Psychosomatic Medicine, 62, 413-422.
Revicki, D. A., Wu, A. W., and Murray, M. I. (1995). Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care, 33, AS173-AS182.
Revicki, D. A., Moyle, G., Stellbrink, H. J., and Barker, C. (1999). Quality of life outcomes of combination zalcitabine–zidovudine, saquinavir–zidovudine and saquinavir–zalcitabine–zidovudine therapy for HIV-infected adults with CD4 counts between 50 and 350 per cubic millimeter. AIDS, 13, 851-858.
Samsa, G., Edelman, D., Rothman, M. L., Rhys Williams, G., Lipscomb, J., and Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141-155.
Saunders, D. S., and Burgoyne, R. W. (2002). Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. International Journal of STD and AIDS, 13, 683-690.
Scott-Lennox, J. A., Mills, R. J., and Burt, M. S. (1998). Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life. Annals of Pharmacotherapy, 32, 525-529.
Shafer, R. W., and Vuitton, D. A. (1999). Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomedicine and Pharmacotherapy, 53, 73-86.
Tsevat, J., Solzan, J. G., Kuntz, K. M., Ragland, J., Currier, J. S., Sell, R. L., and Weinstein, M. (1996). Health values of patients infected with human immunodeficiency virus. Medical Care, 34, 44-57.
Tsiodras, S., Mantzoros, C., Hammer, S., and Samore, M. (2000). Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study. Archives of Internal Medicine, 160, 2050-2056.
Vogl, D., Rosenfeld, B., Breitbart, W., Thaler, H., Passik, S., McDonald, M., and Portenoy, R. K. (1999). Symptom prevalence, characteristics, and distress in AIDS outpatients. Journal of Pain and Symptom Management, 18, 253-262.
Wachtel, T., Piette, J., Mor, V., Stein, M., Fleishman, J., and Carpenter, C. (1992). Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study Instrument. Annals of Internal Medicine, 116, 129-137.
Ware, J. E., Snow, K. K., Kosinski, M., and Gandek, B. (1993). SF-36 Health Survey: Manual and interpretation guide. Boston: Health Institute, New England Medical Center.
Ware, J. E., Kosinski, M., and Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user's manual. Boston: Health Assessment Lab, New England Medical Center
Ware, J. E., Kosinski, M., Bayliss, M. S., McHorney, C. A., Rogers, W., and Raczek, A. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 profile and summary measures: Summary of results from the Medical Outcomes Study. Medical Care, 33, AS264-AS279.
Weinfurt, K. P., Willke, R. J., Glick, H. A., Freimuth, W. W., and Shulman, K. (2000). Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Medical Care, 38, 404-410.
Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., and Richman, D. D. (1991). A health status questionnaire using 30 items from the medical outcomes study. Medical Care, 29, 786-798.
Wu, A. W., Rubin, H. R., Mathews, W. C., Brysk, L. M., Bozzette, S. A., Hardy, W. D., Atkinson, J. H., Grant, I., Spector, S. A., McCutchan, J. A., and Richman, D. D. (1993). Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. Journal of AIDS, 6, 452-458.
Zinkernagel, C., Ledergerber, B., Battegay, M., Cone, R. W., Vernazza, P., Hirschel, B., and Opravil, M. (2000). Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. AIDS, 13, 1587-1589.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burgoyne, R.W., Rourke, S.B., Behrens, D.M. et al. Long-Term Quality-of-Life Outcomes Among Adults Living with HIV in the HAART Era: The Interplay of Changes in Clinical Factors and Symptom Profile. AIDS Behav 8, 151–163 (2004). https://doi.org/10.1023/B:AIBE.0000030246.19577.fb
Issue Date:
DOI: https://doi.org/10.1023/B:AIBE.0000030246.19577.fb